Related Experiment Video
Updated: Jul 4, 2026

Prehospital Thrombolysis: A Manual from Berlin
Published on: November 26, 2013
Methodology for antithrombotic and thrombolytic therapy guideline development: American College of Chest Physicians
Holger J Schünemann1, Deborah Cook2, Gordon Guyatt2
1From the Italian National Cancer Institute Regina Elena, Rome, Italy.
Insights
The American College of Chest Physicians developed evidence-based guidelines for antithrombotic and thrombolytic therapy. This rigorous process ensures recommendations are transparent, methodologically sound, and clinically relevant.
Area of Science:
- Medical Guidelines
- Evidence-Based Medicine
- Thrombosis Management
Background:
- The American College of Chest Physicians (ACCP) convened experts to update its evidence-based guidelines.
- Previous guidelines have guided clinical practice in antithrombotic and thrombolytic therapy.
Purpose of the Study:
- To develop the eighth edition of ACCP evidence-based guidelines on antithrombotic and thrombolytic therapy.
- To ensure recommendations are transparent, methodologically sound, and clinically relevant.
Main Methods:
- Expert panel formation including researchers and methodologists.
- Systematic literature searches and rigorous assessment of study quality.
- Explicit definition of clinical questions, eligibility criteria, and grading of recommendations.
Main Results:
- Guidelines organized into chapters linking evidence to recommendations.
- Consideration of resource allocation and economic implications.
- Explicit statement of values and preferences influencing recommendations.
Conclusions:
- The methodology establishes a robust evidence-based approach for guideline development.
- The updated guidelines provide a clear link between evidence and clinical recommendations.
- The process emphasizes transparency, quality assessment, and consideration of patient values.
Abstract:
The American College of Chest Physicians (ACCP) invited a panel of experts, researchers, information scientists, and guideline methodologists to develop the eighth edition of ACCP evidence-based guidelines on antithrombotic and thrombolytic therapy. The process began with guideline authors specifying the population, intervention and alternative, and outcomes for each clinical question and defined criteria for eligible articles, including methodologic criteria, for each recommendation. The McMaster University Evidence-Based Practice Center, in collaboration with the guideline authors and methodologists, developed strategies and executed systematic searches for evidence. The resulting guidelines are organized in chapters that present a clear link between the evidence and the resulting recommendations. The panel identified questions in which resource allocation issues were particularly important and obtained input from consultants with expertise in economic analysis for these issues. Authors paid careful attention to the quality of underlying evidence and the balance between risks and benefits, both reflected in grades of recommendations. For recommendations that are particularly sensitive to underlying values and preferences, the panel made explicit the values underlying the recommendations. Thus, the process of making recommendations for the ACCP guidelines included explicit definition of questions, transparent eligibility criteria for including studies, comprehensive searches and methodologic assessment of studies, and specification of values and preferences and resource implications underlying recommendations where particularly relevant. In combination with our previous practice of grading recommendations according to their strength and the methodologic quality of the supporting studies, these methods establish our guideline methodology as evidence based.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Coronary Artery Disease V: Interprofessional Care
Atherosclerosis III: Management
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Angina IV: Management
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...